Correlation Between Sichuan Hebang and INKON Life
Specify exactly 2 symbols:
By analyzing existing cross correlation between Sichuan Hebang Biotechnology and INKON Life Technology, you can compare the effects of market volatilities on Sichuan Hebang and INKON Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sichuan Hebang with a short position of INKON Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sichuan Hebang and INKON Life.
Diversification Opportunities for Sichuan Hebang and INKON Life
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sichuan and INKON is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Sichuan Hebang Biotechnology and INKON Life Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INKON Life Technology and Sichuan Hebang is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sichuan Hebang Biotechnology are associated (or correlated) with INKON Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INKON Life Technology has no effect on the direction of Sichuan Hebang i.e., Sichuan Hebang and INKON Life go up and down completely randomly.
Pair Corralation between Sichuan Hebang and INKON Life
Assuming the 90 days trading horizon Sichuan Hebang Biotechnology is expected to generate 1.4 times more return on investment than INKON Life. However, Sichuan Hebang is 1.4 times more volatile than INKON Life Technology. It trades about -0.11 of its potential returns per unit of risk. INKON Life Technology is currently generating about -0.31 per unit of risk. If you would invest 210.00 in Sichuan Hebang Biotechnology on October 5, 2024 and sell it today you would lose (15.00) from holding Sichuan Hebang Biotechnology or give up 7.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sichuan Hebang Biotechnology vs. INKON Life Technology
Performance |
Timeline |
Sichuan Hebang Biote |
INKON Life Technology |
Sichuan Hebang and INKON Life Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sichuan Hebang and INKON Life
The main advantage of trading using opposite Sichuan Hebang and INKON Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sichuan Hebang position performs unexpectedly, INKON Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INKON Life will offset losses from the drop in INKON Life's long position.Sichuan Hebang vs. Zijin Mining Group | Sichuan Hebang vs. Wanhua Chemical Group | Sichuan Hebang vs. Baoshan Iron Steel | Sichuan Hebang vs. Shandong Gold Mining |
INKON Life vs. Industrial and Commercial | INKON Life vs. Kweichow Moutai Co | INKON Life vs. Agricultural Bank of | INKON Life vs. China Mobile Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |